Kaiser Permanente has published research in JAMA Pediatrics that showcases the development of a neonatal sepsis risk calculator that has safely reduced antibiotic use by nearly 50 percent in newborns. Read More »
The U.S. Food and Drug Administration has accepted Pfizer's Biologics License Application for inotuzumab ozogamicin. Read More »
Mylan's Biologics License Application for MYL-1401H, a proposed biosimilar to Neulasta (pegfilgrastim), has been accepted by the U.S. Food and Drug Administration. Read More »
AbbVie, a global biopharmaceutical company, recently announced its Viekirax + Exviera eight-week treatment program has been granted a positive opinion by the European Committee for Medicinal Products for Human Use of the European Medicines Agency. Read More »
Pfizer Inc. recently released top-line results for ORAL Strategy, a Phase 3B/4 study of XELJANZ (tofacitinib citrate) 5mg twice daily in the treatment of moderate to severe rheumatoid arthritis. Read More »
The European Commission has adopted a decision to change the Repatha (evolocumab) marketing authorization, approving a new single-dose delivery option. Read More »
Purdue Pharma L.P.'s Maria Barton has been promoted from deputy general counsel to general counsel. Read More »
Genentech, a member of the Roche Group, recently announced its Phase II IMmotion150 study delivered promising results. Read More »
The biggest pharmaceutical event series in the world, the CPhl, will take place May 16-18 in Philadelphia and feature over 55 speakers. Read More »
PharmaCyte Biotech, Inc., announced that they would be winning the 2017 Buzz of BIO "Pipelines of Promise" award prior to the 2017 BIO International Convention. Read More »
![BPX-01[1] is a “non-oil-based topical gel with fully solubilized minocycline.](https://s3.amazonaws.com/jnswire/jns-media/9a/8e/541279/medium_logo.png){kind=logo}
BioPharmX Corp., a leading pharmaceutical company developing and promoting health products for the dermatology and women’s market, revealed it has completed the “last subject visit in its Phase 2b trial,” as of March. Read More »
DelMar Pharmaceuticals Inc., a company fighting for cancer patients and therapies, decreased its public stock aggregate share from 2.77 million to 2.08 million this month. Read More »
Amgen and Novartis are working together to fight against migraines with erenumab, an expanded commercial collaboration building on a global neuroscience collaboration in Alzheimer's disease and migraine established in 2015. Read More »
Teva Pharmaceutical Industries Ltd. has launched AirDuo RespiClick, an inhalation powder for the treatment of asthma in patients 12 and older. Read More »
To make health care more affordable for those who need it, Kmart Pharmacy is reducing the price of epinephrine auto-injector pens. Read More »
Josie Martin has been named vice president of corporate affairs and communications for Purdue Pharma LP. Read More »
The Corporate Whistleblower Center is encouraging individuals to reach out to authorities if they know of unsanitary pharmacy practices. Read More »
The Pharmaceutical Care Management Association is beginning the DrugBenefitSolutions national campaign, in which it seeks to explain how pharmacy benefits managers are helping to reduce the price of medications and assist consumers, as well as employers and unions. Read More »
Biologics Inc., a McKesson Specialty Health oncology pharmacy services company, has been chosen by Tesaro Inc. to provide its new drug. Read More »
Purdue Pharma LP's Carrie Chomiak will be stepping up into a substantial business role as lead of over-the-counter product franchise for brands including Betadine microbicide antiseptics, Slow-Mag magnesium chloride supplements, Senokot laxative and Colace stool softener. Read More »
Alerts Sign-up
